Drug Therapies for Peripheral Joint Disease in Psoriatic Arthritis: A Systematic Review

被引：47

作者：

Acosta Felquer, Maria Laura ^{[1
]}

Coates, Laura C. ^{[2
]}

Soriano, Enrique R. ^{[3
]}

Ranza, Roberto ^{[4
]}

Espinoza, Luis R. ^{[5
]}

Helliwell, Philip S. ^{[6
]}

FitzGerald, Oliver ^{[7
,8
]}

McHugh, Neil ^{[9
]}

Roussou, Euthalia ^{[10
,11
]}

Mease, Philip J. ^{[12
]}

机构：

[1] Hosp Italiano Buenos Aires, Serv Clin Med, Secc Reumatol, Buenos Aires, DF, Argentina

[2] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England

[3] Hosp Italiano Buenos Aires, Serv Clin Med, Secc Reumatol, Caba, Argentina

[4] Univ Fed Uberlandia, Acad Unit Rheumatol, BR-38400 Uberlandia, MG, Brazil

[5] Louisiana State Univ, Hlth Sci Ctr, Rheumatol Sect, New Orleans, LA USA

[6] Chapel Allerton Hosp, Acad Unit Musculoskeletal Dis, Leeds, W Yorkshire, England

[7] Univ Coll Dublin, St Vincents Univ Hosp, Dept Rheumatol, Dublin 2, Ireland

[8] Univ Coll Dublin, Conway Inst Biomol Res, Dublin 2, Ireland

[9] Univ Bath, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England

[10] Barking Havering & Redbridge Univ, NHS Trust, Barking, Essex, England

[11] Queens Marys Univ London, London, England

[12] Univ Washington, Sch Med, Swedish Med Ctr, Seattle, WA USA

来源：

JOURNAL OF RHEUMATOLOGY | 2014年 / 41卷 / 11期

关键词：

NONSTEROIDAL ANTIINFLAMMATORY DRUGS; BIOLOGICS; DISEASE MODIFYING ANTIRHEUMATIC DRUGS; THERAPEUTIC STRATEGIES; TUMOR NECROSIS FACTOR INHIBITORS; ORAL PHOSPHODIESTERASE-4 INHIBITOR; PLACEBO-CONTROLLED TRIAL; GENERALIZED PUSTULAR PSORIASIS; RANDOMIZED CONTROLLED-TRIAL; TERM 52-WEEK IMPROVEMENT; REQUIRING 2ND-LINE DRUGS; P40; MONOCLONAL-ANTIBODY; NECROSIS FACTOR THERAPY; LOW-DOSE INFLIXIMAB; DOUBLE-BLIND;

D O I：

10.3899/jrheum.140876

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

In 2009, GRAPPA published their first evidence-based recommendations for the treatment of psoriasis and psoriatic arthritis (PsA). Since then, new information has been published and drugs developed. We summarize evidence for the efficacy of available treatments for peripheral joint involvement in PsA. We performed a systematic review of current literature on the efficacy of different therapies, management, and therapeutic strategies for peripheral arthritis involvement in PsA, in order to provide information for the development of the new GRAPPA treatment recommendations.

引用

页码：2277 / 2285

页数：9

共 71 条

[61] Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial
Ritchlin, Christopher
Rahman, Proton
Kavanaugh, Arthur
McInnes, Iain B.
Puig, Lluis
Li, Shu
Wang, Yuhua
Shen, Yaung-Kaung
Doyle, Mittie K.
Mendelsohn, Alan M.
Gottlieb, Alice B.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (06) : 990 - 999
[62] Efficacy of infliximab in resistant psoriatic arthritis
Salvarani, C
Cantini, F
Olivieri, I
Macchioni, P
Padula, A
Niccoli, L
Catanoso, MG
Lo Scocco, G
Boiardi, L
[J]. ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2003, 49 (04): : 541 - 545
[63] Sarzi-Puttini P, 2001, CLIN EXP RHEUMATOL, V19, pS17
[64] The effectiveness of a traditional therapeutical approach in early psoriatic arthritis: results of a pilot randomised 6-month trial with methotrexate
Scarpa, Raffaele
Peluso, Rosario
Atteno, Mariangela
Manguso, Francesco
Spano, Angelo
Iervolino, Salvatore
Di Minno, Matteo Nicola Dario
Costa, Luisa
Del Puente, Antonio
[J]. CLINICAL RHEUMATOLOGY, 2008, 27 (07) : 823 - 826
[65] Schett G, 2013, ARTHRITIS RHEUM-US, V65, pS143
[66] Treating axial and peripheral spondyloarthritis, including psoriatic arthritis, to target: results of a systematic literature search to support an international treat-to-target recommendation in spondyloarthritis
Schoels, M. M.
Braun, J.
Dougados, M.
Emery, P.
Fitzgerald, O.
Kavanaugh, A.
Kvien, T. K.
Landewe, R.
Luger, T.
Mease, P.
Olivieri, I.
Reveille, J.
Ritchlin, C.
Rudwaleit, M.
Sieper, J.
Smolen, J. S.
de Wit, M.
van der Heijde, D.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (01) : 238 - 242
[67] Soriano ER, 2006, J RHEUMATOL, V33, P1422
[68] Life-table analysis of etanercept with or without methotrexate in patients with psoriatic arthritis
Spadaro, A.
Ceccarelli, F.
Scrivo, R.
Valesini, G.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (11) : 1650 - 1651
[69] Comparison of two etanercept regimens for treatment of psoriasis and psoriatic arthritis: PRESTA randomised double blind multicentre trial
Sterry, Wolfram
Ortonne, Jean-Paul
Kirkham, Bruce
Brocq, Olivier
Robertson, Deborah
Pedersen, Ronald D.
Estojak, Joanne
Molta, Charles T.
Freundlich, Bruce
[J]. BMJ-BRITISH MEDICAL JOURNAL, 2010, 340 : 300
[70] Infliximab inhibits progression of radiographic damage in patients with active psoriatic arthritis through one year of treatment - Results from the induction and maintenance psoriatic arthritis clinical trial 2
van der Heijde, D.
Kavanaugh, A.
Gladman, D. D.
Antoni, C.
Krueger, G. G.
Guzzo, C.
Zhou, B.
Dooley, L. T.
de Vlam, K.
Geusens, P.
Birbara, C.
Halter, D.
Beutler, A.
[J]. ARTHRITIS AND RHEUMATISM, 2007, 56 (08): : 2698 - 2707

← 1 2 3 4 5 6 7 8 →